Due to the fact that, IGF-I/IGF-IR is a key signaling pathway of bone anabolic processes and established in early reports to regulate osteosarcoma cell proliferation (24) we wanted to verify its putative action on MG63 cell growth and assess possible connection to biglycan effects. This evidence concerns the gene IGF1R and osteosarcoma.